Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands

C Boersma, R Klok, J Bos, Mark Naunton, P Van Den Berg, L Dejong-Van den Berg, M Postma

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	191-196
Number of pages	6
Journal	Applied Health Economics and Health Policy
Volume	4
Issue number	3
Publication status	Published - 2005

Cite this

@article{fa95e34ae6d64f17ae3ab1b8c615110c,

title = "Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands",

author = "C Boersma and R Klok and J Bos and Mark Naunton and {Van Den Berg}, P and {Dejong-Van den Berg}, L and M Postma",

year = "2005",

language = "English",

volume = "4",

pages = "191--196",

journal = "Applied Health Economics and Health Policy",

issn = "1175-5652",

publisher = "Adis International",

number = "3",

}

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine

T2 - a study conducted for the Netherlands

AU - Boersma, C

AU - Klok, R

AU - Bos, J

AU - Naunton, Mark

AU - Van Den Berg, P

AU - Dejong-Van den Berg, L

AU - Postma, M

PY - 2005

Y1 - 2005

M3 - Article

VL - 4

SP - 191

EP - 196

JO - Applied Health Economics and Health Policy

JF - Applied Health Economics and Health Policy

SN - 1175-5652

IS - 3

ER -